Prognostic Factors for Survival in Patients With Unresectable Pancreatic Cancer
Authors:
- 1 November 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Pancreas
- Vol. 39 (8) , 1247-1253
Abstract
Objectives: In patients with unresectable pancreatic cancer, estimation of individual prognosis is essential to provide the most suitable biliary stent (self-expanding metal stent or plastic stent). The aim of the current study was to determine prognostic factors for survival in patients with unresectable pancreatic cancer after initial biliary drainage. Patients and Methods: The current study included 278 patients with unresectable pancreatic cancer. Prognostic factors for survival were analyzed using the Cox proportional hazards model, the Kaplan-Meier survival estimator, and the Wilcoxon test for difference in survival. Results: In univariate analysis, advanced T stage according to the TNM classification (P = 0.021, Wald test) and the presence of distant metastases (P = 0.001, Wald test) were predictive factors for shorter survival. However, in multivariate analysis, the presence of distant metastasis was the only independent prognostic factor. The median survival time after initial biliary drainage was 3.1 and 6.6 months in patients with and without the presence of distant metastases, respectively. Conclusions: The presence of distant metastases was identified as the only independent prognostic factor for survival after initial biliary drainage. A self-expanding metal stent should be systematically chosen for patient without distant metastases, whereas polyethylene plastic stents should be preferred in patients with distant metastases.Keywords
This publication has 20 references indexed in Scilit:
- Tannenbaum and metal stents in the palliative treatment of malignant distal bile duct obstruction: a comparative study of patency and cost effectivenessSurgical Endoscopy, 2006
- Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trialGastrointestinal Endoscopy, 2006
- Pancreatic Cancer: Basic and Clinical AspectsGastroenterology, 2005
- Endoscopic Stenting for Biliary and Pancreatic MalignanciesJournal of Clinical Gastroenterology, 2004
- Endoscopic treatment of pancreatico-biliary malignanciesCritical Reviews in Oncology/Hematology, 2001
- Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database11No competing interests declared.Journal of the American College of Surgeons, 1999
- Prognostic Factors in Nonresectable Pancreatic Adenocarcinoma: A Rationale to Design Therapeutic TrialsAmerican Journal of Gastroenterology, 1999
- Comparative costs of metal versus plastic biliary stent strategies for malignant obstructive jaundice by decision analysisGastrointestinal Endoscopy, 1999
- Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guidelineGut, 1998
- Symptom relief and quality of life after stenting for malignant bile duct obstruction.Gut, 1994